Form 8-K - Current report:
SEC Accession No. 0001213900-25-042663
Filing Date
2025-05-13
Accepted
2025-05-13 16:15:21
Documents
15
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0241986-8k_therap.htm   iXBRL 8-K 30478
2 PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED MAY 13, 2025, ENTITLED "THERAPEUT ea024198601ex99-1_therap.htm EX-99.1 18068
3 GRAPHIC ex99-1_001.jpg GRAPHIC 16004
  Complete submission text file 0001213900-25-042663.txt   249272

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE txmd-20250513.xsd EX-101.SCH 3032
5 XBRL LABEL FILE txmd-20250513_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE txmd-20250513_pre.xml EX-101.PRE 22370
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0241986-8k_therap_htm.xml XML 3679
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 25940313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)